NRX Pharmaceuticals annual gross margin
2025
NRX Pharmaceuticals Gross Margin Growth & History (NRXP)
NRX Pharmaceuticals's gross margin was 58.78% for fiscal 2025.
View full NRX Pharmaceuticals company overviewNRX Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 58.78% | — |
NRX Pharmaceuticals quarterly gross margin
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 38.69% | — |
| Q1 2026 | 2026-03-31 | 40.92% | — |
| Q4 2025 | 2025-12-31 | 58.49% | — |
| Q3 2025 | 2025-09-30 | 59.92% | — |
NRX Pharmaceuticals gross margin trends
The latest reported quarter, Q2 2026, shows 38.69%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NRX Pharmaceuticals source filings ↗